Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, fixed-sequence, nonrandomized, open-label study in
healthy adults to investigate the impact of rifabutin on the pharmacokinetics of trikafta.